Showing results (141-150 of 245) with videos related to
Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|October 4, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2Wei Wang, Amy K Erbe, Mikayla Gallenberger, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.Nature Communications|August 25, 2022
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1Hsiao-Yun Chen, Yavuz T Durmaz, Yixiang Li, et al.Journal for Immunotherapy of Cancer|March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0Rana R McKay, Archana Ajmera, Michael B Atkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell CarcinomaAmy K Erbe, Wei Wang, Jacob Goldberg, et al.Plos One|August 2, 2014
Identification of ALK gene alterations in urothelial carcinomaJoaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.Iscience|February 8, 2024
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse modelYufei Wang, Jae-Won Cho, Gabriella Kastrunes, et al.Oncotarget|May 5, 2016
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulationJianmin Wang, Antonios Papanicolau-Sengos, Sreenivasulu Chintala, et al.Nature Genetics|June 4, 2013
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasionGuocan Wang, Andrea Lunardi, Jiangwen Zhang, et al.Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.Pageof 25